Home > > > > > Report Detail

Multiple Sclerosis Drugs Market Global Report 2020-30

Publisher Name :
Date: 10-Apr-2020
No. of pages: 200

Multiple Sclerosis Drugs Market Global Report 2020-30 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global multiple sclerosis drugs market.

Reasons to Purchase

- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.

- Create regional and country strategies on the basis of local data and analysis.

- Identify growth segments for investment.

- Outperform competitors using forecast data and the drivers and trends shaping the market.

- Understand customers based on the latest market research findings.

- Benchmark performance against key competitors.

- Utilize the relationships between key data sets for superior strategizing.

- Suitable for supporting your internal and external presentations with reliable high quality data and analysis

- Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the multiple sclerosis drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Multiple Sclerosis Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider multiple sclerosis drugs market, and compares it with other markets.

- The market characteristics section of the report defines and explains the market.

- The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

- Market segmentations break down market into sub markets.

- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

- The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

- The multiple sclerosis drugs market section of the report gives context. It compares the multiple sclerosis drugs market with other segments of the multiple sclerosis drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, multiple sclerosis drugs indicators comparison.

Scope

Markets Covered: 1) By Drug Class: Immunomodulators; Immunosuppressants; Interferons; Others; 2) By Distribution Channels: Hospital Pharmacy; Retail Pharmacy; Online Stores; 3) By Route Of Administration: Oral Drugs; Parenteral Drugs

Companies Mentioned: Biogen; Novartis; Roche; Bayer HealthCare; Pfizer, Inc.

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Multiple Sclerosis Drugs Market Global Report 2020-30

Table of Contents

1. Executive Summary
2. Multiple Sclerosis Drugs Market Characteristics
3. Multiple Sclerosis Drugs Market Size And Growth
3.1. Global Multiple Sclerosis Drugs Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Multiple Sclerosis Drugs Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Multiple Sclerosis Drugs Market Segmentation
4.1. Global Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Immunomodulators
Immunosuppressants
Interferons
Others
4.2. Global Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Stores
4.3. Global Multiple Sclerosis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Oral drugs
Parenteral drugs
5. Multiple Sclerosis Drugs Market Regional And Country Analysis
5.1. Global Multiple Sclerosis Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Multiple Sclerosis Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific Multiple Sclerosis Drugs Market
6.1. Asia-Pacific Multiple Sclerosis Drugs Market Overview
6.2. Asia-Pacific Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
7. China Multiple Sclerosis Drugs Market
7.1. China Multiple Sclerosis Drugs Market Overview
7.2. China Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
8. India Multiple Sclerosis Drugs Market
8.1. India Multiple Sclerosis Drugs Market Overview
8.2. India Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9. Japan Multiple Sclerosis Drugs Market
9.1. Japan Multiple Sclerosis Drugs Market Overview
9.2. Japan Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10. Australia Multiple Sclerosis Drugs Market
10.1. Australia Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11. Indonesia Multiple Sclerosis Drugs Market
11.1. Indonesia Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12. South Korea Multiple Sclerosis Drugs Market
12.1. South Korea Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13. Western Europe Multiple Sclerosis Drugs Market
13.1. Western Europe Multiple Sclerosis Drugs Market Overview
13.2. Western Europe Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14. UK Multiple Sclerosis Drugs Market
14.1. UK Multiple Sclerosis Drugs Market Overview
14.2. UK Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15. Germany Multiple Sclerosis Drugs Market
15.1. Germany Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16. France Multiple Sclerosis Drugs Market
16.4. France Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17. Eastern Europe Multiple Sclerosis Drugs Market
17.1. Eastern Europe Multiple Sclerosis Drugs Market Overview
17.2. Eastern Europe Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18. Russia Multiple Sclerosis Drugs Market
18.1. Russia Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19. North America Multiple Sclerosis Drugs Market
19.1. North America Multiple Sclerosis Drugs Market Overview
19.2. North America Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20. USA Multiple Sclerosis Drugs Market
20.1. USA Multiple Sclerosis Drugs Market Overview
20.2. USA Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21. South America Multiple Sclerosis Drugs Market
21.1. South America Multiple Sclerosis Drugs Market Overview
21.2. South America Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22. Brazil Multiple Sclerosis Drugs Market
22.1. Brazil Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23. Middle East Multiple Sclerosis Drugs Market
23.1. Middle East Multiple Sclerosis Drugs Market Overview
23.2. Middle East Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24. Africa Multiple Sclerosis Drugs Market
24.1. Africa Multiple Sclerosis Drugs Market Overview
24.2. Africa Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
25. Multiple Sclerosis Drugs Market Competitive Landscape And Company Profiles
25.1. Multiple Sclerosis Drugs Market Competitive Landscape
25.2. Multiple Sclerosis Drugs Market Company Profiles
25.2.1. Biogen
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Novartis
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Roche
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Bayer HealthCare
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Pfizer, Inc.
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Multiple Sclerosis Drugs Market
27. Multiple Sclerosis Drugs Market Trends And Strategies
28. Multiple Sclerosis Drugs Market Future Outlook and Potential Analysis
29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. The Business Research Company
29.5. Copyright And Disclaimer

List of Tables

Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 3: Global Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 4: Global Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 5: Global Multiple Sclerosis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 6: Global Multiple Sclerosis Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 7: Global Multiple Sclerosis Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 8: Asia-Pacific, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 9: Asia-Pacific, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 10: China, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 11: China, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 12: India, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 13: India, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 14: Japan, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 15: Japan, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 16: Australia, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 17: Australia, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 18: Indonesia, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 19: Indonesia, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 20: South Korea, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 21: South Korea, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 22: Western Europe, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 23: Western Europe, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 24: UK, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 25: UK, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 26: Germany, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 27: Germany, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 28: France, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 29: France, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 30: Eastern Europe, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 31: Eastern Europe, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 32: Russia, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 33: Russia, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 34: North America, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 35: North America, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 36: USA, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 37: USA, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 38: South America, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 39: South America, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 40: Brazil, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 41: Brazil, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 42: Middle East, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 43: Middle East, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 44: Africa, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 45: Africa, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 46: Biogen Financial Performance
Table 47: Novartis Financial Performance
Table 48: Roche Financial Performance
Table 49: Bayer HealthCare Financial Performance
Table 50: Pfizer, Inc. Financial Performance

List of Figures

Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 3: Global Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 4: Global Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 5: Global Multiple Sclerosis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 6: Global Multiple Sclerosis Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 7: Global Multiple Sclerosis Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 8: Asia-Pacific, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 9: Asia-Pacific, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 10: China, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 11: China, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 12: India, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 13: India, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 14: Japan, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 15: Japan, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 16: Australia, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 17: Australia, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 18: Indonesia, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 19: Indonesia, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 20: South Korea, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 21: South Korea, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 22: Western Europe, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 23: Western Europe, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 24: UK, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 25: UK, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 26: Germany, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 27: Germany, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 28: France, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 29: France, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 30: Eastern Europe, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 31: Eastern Europe, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 32: Russia, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 33: Russia, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 34: North America, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 35: North America, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 36: USA, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 37: USA, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 38: South America, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 39: South America, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 40: Brazil, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 41: Brazil, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 42: Middle East, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 43: Middle East, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 44: Africa, Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 45: Africa, Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 46: Biogen Financial Performance
Figure 47: Novartis Financial Performance
Figure 48: Roche Financial Performance
Figure 49: Bayer HealthCare Financial Performance
Figure 50: Pfizer, Inc. Financial Performance
  • Global Fingolimod Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Fingolimod market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Multiple Sclerosis Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Multiple Sclerosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiple Sclerosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provi......
  • Global Multiple Sclerosis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Multiple Sclerosis market: According to our latest research, the global Multiple Sclerosis market looks promising in the next 5 years. As of 2022, the global Multiple Sclerosis market was estimated at USD 13809.22 million, and it's anticipated to reach USD 21672.55 million in 2028, with a CAGR of 7.8% during the forecast years. Multiple sclerosis (MS) is a chronic inflammatory neuropathy characterized by demyelination, axonal transection, and neurode......
  • Fingolimod - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 77
    The global Fingolimod market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fingolimod in various end use industries. The expanding demands from the Medical Field, Science Research Field and Other Fields,, are propelling Fingolimod market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inj......
  • Global Fingolimod Market Research Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 2680 Onwards        Pages: 133
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Fingolimod Professional Survey Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Multiple Sclerosis Drugs - Global Market Insights and Sales Trends 2024
    Published: 19-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Multiple Sclerosis Drugs, with both qu......
  • Global Multiple Sclerosis Drugs Market Research Report 2023
    Published: 25-Oct-2023        Price: US 2900 Onwards        Pages: 87
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multiple Sclerosis Drugs market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Biogen - Sanofi - Novartis - Teva - Merck KGaA - Bayer - ACORDA - Mallinckrodt Segment by Type - Injectable......
  • Global Multiple Sclerosis Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 13-Jun-2023        Price: US 3260 Onwards        Pages: 122
    Multiple sclerosis (MS) is the most common disabling neurological disease in young people worldwide. The Multiple Sclerosis Drugs market revenue was 15099.44 Million USD in 2022, and will reach 23584.78 Million USD in 2028, with a CAGR of 7.72% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Multiple Sclerosis Drugs industry, and breaks down according to the type, application, and consumption area of Multiple Sclero......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs